2030年までの人工涙液予測

Artificial Tears Forecast till 2030

2030年までの人工涙液予測市場概要ドライアイ感染症や目の炎症が蔓延し、無添加アイテムへの志向が高まっていることが市場発展の原動力となっている。特に中等度または重度のドライアイに対する添加物の... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年11月10日	US$7,250 ライセンス・価格情報注文方法はこちら	128	英語

目次
図表リスト

サマリー

2030年までの人工涙液予測

市場概要
ドライアイ感染症や目の炎症が蔓延し、無添加アイテムへの志向が高まっていることが市場発展の原動力となっている。
特に中等度または重度のドライアイに対する添加物の眼障害などの結果から推測される無添加人工涙液への関心の高まりが、人工涙液市場を牽引している。さらに、重要な参加者によるアイテム派遣数の増加が、アイテムの分離を拡大し、結果として市場発展を促進している。例えば、2022年1月、Alcon社（スイス）は欧州市場でSystane完全無添加オイル目薬を送り出した。同様に、2019年10月、Allergan, Inc.（米国AbbVieのAuxiliary）は、Reviveポートフォリオを拡張したInvigorate Relievaグリース目薬製品を発売した。同製品には、リバイブリリーバPF（無添加）マルチドーズが含まれる。
さらに、無添加アイテムの派遣拡大が人工涙液市場を牽引している。さらに、無添加目薬の汚染防止のための包装計画や搬送システムの推進が、人工涙液市場をさらに牽引している。したがって、無添加アイテムへの傾斜の拡大が市場発展の原動力となっている。
市場細分化
人工涙液市場はタイプ別に、セルロース、グリセリン、プロピレングリコール、ポリエチレングリコールなどのセグメントに分けられる。人工涙液市場は、点眼剤、軟膏剤、スプレー剤に分けられる。
人工涙液市場の用途分野では、ドライアイ、アレルギー、感染症などに分類される。病院薬局、ドラッグストア、小売薬局、インターネット薬局などが流通システムの一部である。
地域別洞察
北米の人工涙液市場は、ドライアイ疾患の一般性、市場参入者の存在、同地域におけるコンタクトフォーカルポイントへの関心の高まりにより、最大の市場を占めた。ドライアイ疾患は、米国では非常に広範囲に及んでおり、特に50歳以上の人口の膨大なレベルに影響を及ぼしている。
ヨーロッパ人工涙液市場は、眼科疾患の蔓延、最先端目薬の利用拡大、急速な人口の増加により、第2位の市場となっている。
アジア太平洋人工涙液市場は、レビュー期間中に速い速度で発展すると思われる。これは、アジア太平洋地域の人口が底堅く、視覚疾患に対する意識が高まり、医療サービスの消費が拡大しているためである。また、中国人工涙液市場は最大の市場提供を保持し、インド人工涙液市場はアジア太平洋地域で最も急速に発展する市場である。
主要企業
世界の人工涙液市場の主要企業は、ジョンソン・エンド・ジョンソンビジョンケア（米国）、アラガン社（アイルランド）、アルコン社（スイス）、ボシュロム社（カナダ）、参天製薬（日本）、ウルサファーム社（ドイツ）、ロート製薬（日本）、シミラサン社（米国）、Ocusoft社（米国）、ニコックス社（フランス）である。

ページTOPに戻る

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF DRY EYE DISEASE AND EYE INFLAMMATION

4.2.2 RISING PREFERENCE FOR PRESERVATIVE-FREE PRODUCTS

4.3 RESTRAINTS

4.3.1 SIDE-EFFECTS AND ALLERGIC REACTIONS

4.4 OPPORTUNITIES

4.4.1 ADVANCEMENT IN DIAGNOSTICS FOR DRY EYE DISEASE

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE ARTIFICIAL TEARS MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON MANUFACTURERS

5.4 PRICING ANALYSIS

6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE

6.1 OVERVIEW

6.2 POLYETHYLENE GLYCOL

6.3 PROPYLENE GLYCOL

6.4 CELLULOSE

6.5 GLYCERIN

6.6 OTHERS

7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE

7.1 OVERVIEW

7.2 EYE DROPS

7.3 OINTMENTS

7.4 SPRAYS

8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 DRY EYE SYNDROME

8.3 ALLERGIES AND INFECTIONS

8.4 OTHERS

9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 HOSPITAL PHARMACIES

9.3 DRUG STORES

9.4 RETAIL PHARMACIES

9.5 ONLINE PHARMACIES

10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 UK

10.3.3 FRANCE

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.7.1 PRODUCT LAUNCH

11.7.2 COLLABORATION

11.7.3 AGREEMENT

11.7.4 ACQUISITION

11.7.5 PARTNERSHIP

11.8 MAJOR PLAYERS FINANCIAL MATRIX

11.8.1 SALES (USD BILLION), 2022

11.8.2 R&D (USD BILLION), 2022

12 COMPANY PROFILES

12.1 JOHNSON AND JOHNSON VISION CARE

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 ALLERGAN PLC

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 ALCON PLC

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 BAUSCH & LOMB INCORPORATED

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 SANTEN, INC.

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 URSAPHARM ARZNEIMITTEL GMBH

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 ROHTO PHARMACEUTICAL CO., LTD.

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 KEY STRATEGIES

12.8 SIMILASAN CORPORATION

12.8.1 COMPANY OVERVIEWS

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 KEY STRATEGIES

12.9 OCUSOFT

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

12.10 NICOX

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

ページTOPに戻る

図表リスト

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 4 GLOBAL ARTIFICIAL TEARS MARKET, FOR POLYETHYLENE GLYCOL, BY REGION, 2019–2030 (USD BILLION)

TABLE 5 GLOBAL ARTIFICIAL TEARS MARKET, FOR PROPYLENE GLYCOL, BY REGION, 2019–2030 (USD BILLION)

TABLE 6 GLOBAL ARTIFICIAL TEARS MARKET, FOR CELLULOSE, BY REGION, 2019–2030 (USD BILLION)

TABLE 7 GLOBAL ARTIFICIAL TEARS MARKET, FOR GLYCERIN, BY REGION, 2019–2030 (USD BILLION)

TABLE 8 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 10 GLOBAL ARTIFICIAL TEARS MARKET, FOR EYE DROPS, BY REGION, 2019–2030 (USD BILLION)

TABLE 11 GLOBAL ARTIFICIAL TEARS MARKET, FOR OINTMENTS, BY REGION, 2019–2030 (USD BILLION)

TABLE 12 GLOBAL ARTIFICIAL TEARS MARKET, FOR SPRAYS, BY REGION, 2019–2030 (USD BILLION)

TABLE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 14 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRY EYE SYNDROME, BY REGION, 2019–2030 (USD BILLION)

TABLE 15 GLOBAL ARTIFICIAL TEARS MARKET, FOR ALLERGIES AND INFECTIONS, BY REGION, 2019–2030 (USD BILLION)

TABLE 16 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 18 GLOBAL ARTIFICIAL TEARS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 19 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRUG STORES, BY REGION, 2019–2030 (USD BILLION)

TABLE 20 GLOBAL ARTIFICIAL TEARS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 21 GLOBAL ARTIFICIAL TEARS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 22 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2019–2030 (USD BILLION)

TABLE 23 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 24 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 25 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 26 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 27 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 28 US: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 29 US: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 30 US: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 31 US: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 32 CANADA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 33 CANADA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 34 CANADA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 35 CANADA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 36 EUROPE: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 37 EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 38 EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 39 EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 40 EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 41 GERMANY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 42 GERMANY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 43 GERMANY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 44 GERMANY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 45 UK: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 46 UK: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 47 UK: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 48 UK: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 49 FRANCE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 50 FRANCE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 51 FRANCE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 52 FRANCE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 53 ITALY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 54 ITALY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 55 ITALY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 56 ITALY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 57 SPAIN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 58 SPAIN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 59 SPAIN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 60 SPAIN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 61 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 62 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 63 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 64 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 65 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 66 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 67 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 68 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 69 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 70 JAPAN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 71 JAPAN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 72 JAPAN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 73 JAPAN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 74 CHINA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 75 CHINA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 76 CHINA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 77 CHINA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 78 INDIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 79 INDIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 80 INDIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 81 INDIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 82 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 83 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 84 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 85 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 86 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 87 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 88 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 89 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 90 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 91 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 92 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 93 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 94 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 95 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 96 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 97 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 98 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 99 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 100 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 101 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 102 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 103 AFRICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 104 AFRICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 105 AFRICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 106 AFRICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 107 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019–2030 (USD BILLION)

TABLE 108 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019–2030 (USD BILLION)

TABLE 109 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 110 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 111 MAJOR PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET

TABLE 2 MOST ACTIVE PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET

TABLE 3 PRODUCT LAUNCH

TABLE 4 COLLABORATION

TABLE 5 AGREEMENT

TABLE 6 ACQUISITION

TABLE 7 PARTNERSHIP

TABLE 8 JOHNSON AND JOHNSON VISION: PRODUCTS OFFERED

TABLE 9 ALLERGAN PLC: PRODUCTS OFFERED

TABLE 10 ALLERGAN PLC: KEY DEVELOPMENTS

TABLE 11 ALCON PLC: PRODUCTS OFFERED

TABLE 12 ALCON PLC: KEY DEVELOPMENTS

TABLE 13 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED

TABLE 14 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS

TABLE 15 SANTEN PHARMACEUTICALS INC.: PRODUCTS OFFERED

TABLE 16 URSAPHARM ARZNEIMITTEL GMBH: PRODUCTS OFFERED

TABLE 17 URSAPHARM ARZNEIMITTEL GMBH: KEY DEVELOPMENTS

TABLE 18 ROHTO PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED

TABLE 19 ROHTO PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS

TABLE 20 SIMILASAN CORPORATION: PRODUCTS OFFERED

TABLE 21 OCUSOFT: PRODUCTS OFFERED

TABLE 22 OCUSOFT: KEY DEVELOPMENTS

TABLE 23 NICOX: PRODUCTS OFFERED

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Artificial Tears Forecast till 2030

Market Overview
The rising pervasiveness of dry eye infection and eye irritation, and the rising inclination for additive free items are driving market development.
The rising interest for additive free artificial tears inferable from the results of additives including eye disturbance, particularly for moderate or serious dry eyes is driving the artificial tears market. Moreover, the rising number of item dispatches by vital participants is expanding item separation and consequently driving market development. For example, In January 2022, Alcon (Switzerland) sent off Systane complete additive free oil eye drops in the European market. Similarly, in October 2019, Allergan, Inc. (Auxiliary of AbbVie, US) sent off the Invigorate Relieva grease eye drop product offering, an extension of the Revive portfolio. The product offering included Revive Relieva PF (additive free) multidose.
Moreover, expanding item dispatches for additive free items is driving the artificial tears market. Besides, propels in bundling plan and conveyance systems for additive free eye drops to forestall tainting are further driving the market for artificial tears market. Hence, expanding inclination for additive free items is driving the market development.
Market Segmentation
Based on type, the Artificial Tears Market is divided into segments such as cellulose, glycerin, propylene glycol, and polyethylene glycol. The market is separated into eye drops, ointments, and sprays based on the mechanism of delivery.
The dry eye condition, allergies, infections, and other conditions are categorized under the application sector of the artificial tears market. Hospital pharmacies, drug stores, retail pharmacies, and internet pharmacies are all part of the distribution system.
Regional Insights
The North America artificial tears market represented the largest market owing to the of the great commonness of dry eye sickness, the presence of market vital participants, and the developing interest for contact focal points in the region Dry eye illness is exceptionally far reaching in the US, influencing a huge level of the populace, especially those beyond 50 years old.
Europe artificial tears market represents the second-largest market owing to the great pervasiveness of ophthalmic issues, expanding utilization of cutting-edge eye drops, and a quickly flooding maturing populace. further, UK artificial tears market was credited to hold the biggest market share, and the France artificial tears market is supposed to quickest developing market in the European region.
The Asia-Pacific artificial tears market is supposed to develop at a fast rate during the review period. This is because of the solid likely persistent populace, rising consciousness of visual illnesses, and expanding medical services consumption in the Asia-Pacific region. Besides, China artificial tears market is supposed to hold the biggest market offer, and India artificial tears market is normal quickest developing market in the Asia-Pacific region.
Major Players
Key Companies in the worldwide Artificial Tears Market are Johnson and Johnson Vision Care (US), Allergan plc (Ireland), Alcon Plc (Switzerland), Bausch & Lomb Incorporated (Canada), Santen, Inc (Japan), URSAPHARM Arzneimittel GmbH (Germany), ROHTO Pharmaceutical CO., LTD (Japan), Similasan Corporation (US), Ocusoft (US), and Nicox (France).

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

2030年までの人工涙液予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?